---
title: "Hong Kong Stock Movement Update: BIOCYTOGEN-B surges 25%, Qian Xun Technology falls nearly 17%, attracting attention"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274233778.md"
description: "In the past hour, the Hong Kong stock market has shown a clear divergence, with technology stocks and energy stocks performing particularly well. The strong rise of BIOCYTOGEN-B has attracted market attention, driving activity in related sectors. Meanwhile, the decline of Qian Xun Technology reflects cautious sentiment among investors, with short-term enthusiasm seemingly waning. Overall, the market has experienced significant volatility, with funds frequently switching preferences between strong stocks and underperforming stocks, creating a tight rhythm. The stock with the largest movement in the past hour, BIOCYTOGEN-B, surged 25.00%, becoming the market focus. Its strong performance has drawn a large influx of short-term funds, rapidly pushing its price up, and market sentiment has also surged, seemingly indicating investors' optimistic expectations for its future prospects. 

Strong stocks:
1. DINGYI GP INV: up 16.18%, with strong buying in the market, the stock price continues to rise, showing a preference for funds.
2. CHINA CBM: up 15.38%, benefiting from the recovery in energy demand, the stock price has been active, attracting attention from short-term funds.
3. YOFC: up 10.84%, against the backdrop of industry recovery, the stock price has steadily risen, and market sentiment is gradually warming.

Underperforming stocks:
1. Qian Xun Technology: down 16.93%, lacking positive news recently, market sentiment has turned cautious, leading to pressure on the stock price.
2. CSPC PHARMA: down 10.48%, amid overall market volatility, this stock has shown weakness, with noticeable fund outflows"
datetime: "2026-01-30T02:00:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274233778.md)
  - [en](https://longbridge.com/en/news/274233778.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274233778.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274233778.md) | [繁體中文](https://longbridge.com/zh-HK/news/274233778.md)


# Hong Kong Stock Movement Update: BIOCYTOGEN-B surges 25%, Qian Xun Technology falls nearly 17%, attracting attention

**Hong Kong Stock Market Overview in the Last Hour**

The overall market shows a clear trend of differentiation, with technology stocks and energy stocks performing particularly well. The strong rise of BIOCYTOGEN-B has attracted market attention, driving activity in related sectors. Meanwhile, the decline of Qian Xun Technology reflects cautious sentiment among investors, and short-term enthusiasm seems to have weakened. Overall, the market has experienced significant volatility, with funds frequently switching preferences between strong stocks and underperforming stocks, creating a tight rhythm.

**Stocks with the Most Significant Movements in the Last Hour**

BIOCYTOGEN-B surged 25.00%, becoming the market's focal point. The strong performance of this stock has attracted a large influx of short-term funds, pushing its price up rapidly, and market sentiment has also risen, seemingly indicating investors' optimistic expectations for its future prospects.

**Strong Stocks**

1.  DINGYI GP INV: Up 16.18%, with strong buying in the market, the stock price continues to rise, showing a preference for funds.
    
2.  CHINA CBM: Up 15.38%, benefiting from the recovery in energy demand, the stock price has been active, attracting attention from many short-term funds.
    
3.  YOFC: Up 10.84%, against the backdrop of industry recovery, the stock price has steadily risen, and market sentiment is gradually warming.
    

**Underperforming Stocks**

1.  Qian Xun Technology: Down 16.93%, lacking positive news recently, market sentiment has turned cautious, leading to pressure on the stock price.
    
2.  CSPC PHARMA: Down 10.48%, amid overall market volatility, this stock has shown weakness, with noticeable fund outflows.
    
3.  GT GOLD: Down 10.13%, influenced by market sentiment, the stock price continues to decline, and short-term funds are choosing to wait and see

### Related Stocks

- [BIOCYTOGEN-B (02315.HK)](https://longbridge.com/en/quote/02315.HK.md)
- [Qian Xun Technology (01640.HK)](https://longbridge.com/en/quote/01640.HK.md)
- [DINGYI GP INV (00508.HK)](https://longbridge.com/en/quote/00508.HK.md)
- [CHINA CBM (08270.HK)](https://longbridge.com/en/quote/08270.HK.md)
- [YOFC (06869.HK)](https://longbridge.com/en/quote/06869.HK.md)
- [CSPC PHARMA (01093.HK)](https://longbridge.com/en/quote/01093.HK.md)
- [GT GOLD (08299.HK)](https://longbridge.com/en/quote/08299.HK.md)

## Related News & Research

- [Older workers embrace job hopping - and it's good for their retirement prospects](https://longbridge.com/en/news/278136902.md)
- [Billionaire investor Chamath Palihapitiya sparred with an X user over an investment loss — then offered to fund his daughters' college](https://longbridge.com/en/news/278056171.md)
- [Bessent Says US to Enact Measures to Support Gulf Oil Trade, Roll Out 15% Global Tariff This Week](https://longbridge.com/en/news/277787305.md)
- [A Look At Fugro’s (ENXTAM:FUR) Valuation After Its Full Year 2025 Earnings Loss](https://longbridge.com/en/news/277842413.md)
- [Buy Rating on Automotive Properties REIT Driven by Robust FFO Growth, Accretive Acquisitions, and Valuation Upside to NAV](https://longbridge.com/en/news/277983723.md)